Related Articles
Fatty liver and alteration of the gut microbiome induced by diallyl disulfide
Dihydroartemisinin suppresses the proliferation of Epstein‑Barr virus‑associated gastric carcinoma cells via downregulation of latent membrane protein 2A
Characteristics of mouse intestinal microbiota during acute liver injury and repair following 50% partial hepatectomy
Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic‑associated fatty liver disease in mice
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells